Navigating Fertility Treatments After Cancer: Empowering Survivors to Build Families

Medically Reviewed by Dr. Silvana Chedid on September 9, 2026

A cancer diagnosis raises many concerns, and for patients of reproductive age, the effect on future fertility is often one of the most pressing. Chemotherapy, radiation, and some surgeries can reduce egg or sperm quality, damage reproductive organs, or bring on early menopause, though the extent of this impact varies by cancer type, treatment protocol, and age at diagnosis. Once treatment is finished, many survivors still have realistic options for building a family, whether they preserved eggs, sperm, or embryos beforehand or are starting fresh after treatment.

At Chedid Grieco, we work with cancer survivors at every stage of this process, from reviewing what treatment may have changed to planning IVF, egg donation, or other options once an oncologist has cleared a patient to move forward. With decades of experience in reproductive medicine, our team is used to working alongside oncology teams to build a plan that respects both a patient’s cancer history and their family-building goals. This article focuses on life after treatment; if you are still preparing for cancer treatment, our companion article on fertility preservation for patients starting cancer treatment covers that stage in detail.

How Cancer Treatment Affects Fertility

Cancer treatments, while life-saving, can affect reproductive health in both men and women. Chemotherapy, radiation therapy, and some surgical procedures may affect hormone production, the reproductive organs themselves, including the ovaries, uterus, or testicles, and the quality and quantity of eggs or sperm.

The extent of these effects depends on the type of cancer, the treatment protocol used, a patient’s age at diagnosis, and individual health factors. For women, cancer treatment may cause early menopause, damage to the ovaries, or hormone changes that affect ovulation and egg quality, and pelvic radiation can also affect the uterus and its ability to carry a pregnancy. Men may experience reduced sperm production, changes in sperm quality, or reproductive organ damage. Fertility impacts vary a great deal between individuals, and many people retain some reproductive function after treatment, though this cannot be predicted with certainty for any one patient.

Checking Your Fertility After Cancer Treatment

Because the effects of treatment are so individual, the first step after cancer care is usually a fresh look at current reproductive function rather than assumptions based on the diagnosis. The American Society of Clinical Oncology’s 2025 guideline update recommends that clinicians discuss reproductive risk not only at diagnosis but also during survivorship, which reflects how much a patient’s situation can change after treatment ends.

For women, an evaluation typically includes hormone testing such as anti-Mullerian hormone (AMH) and an antral follicle count ultrasound to estimate ovarian reserve, along with an assessment of the uterus when pelvic radiation or surgery was part of treatment. For men, a semen analysis shows whether sperm production has recovered, which can take months or longer after some chemotherapy regimens. These results help us decide whether a patient’s own eggs or sperm are a realistic starting point, or whether previously frozen samples or donor options deserve a closer look.

Your Options if You Preserved Fertility Before Treatment

Patients who froze eggs, sperm, embryos, or ovarian tissue before treatment generally have more options later. Frozen embryos can be thawed and transferred once a patient is cleared for pregnancy, frozen eggs can be thawed and fertilized through in vitro fertilization, and frozen sperm can be used for IVF or, in some cases, IUI. Ovarian tissue that was frozen before treatment can, for selected patients, be transplanted back to restore hormone production and the chance of pregnancy.

If your samples were frozen at another clinic, we can help coordinate records and, where appropriate, the transfer of stored material. Our fertility preservation options page explains how samples are stored, and the timing of when to use them is a decision made together with your oncology team.

Your Options if You Did Not Preserve Fertility

Not every patient has the time or the opportunity to preserve fertility before treatment begins, and that does not close the door on parenthood. Cancer survivors have access to a range of assisted reproductive technologies, and the most appropriate option depends on their specific fertility status and overall health following treatment.

Treatment options for cancer survivors include the following:

• IVF using a survivor’s own eggs or sperm when testing shows enough reproductive function remains
• Egg donation for patients whose ovarian function has been significantly affected
• Donor sperm for patients experiencing fertility challenges following treatment
• Gestational surrogacy, when carrying a pregnancy is not medically advisable
• Testicular sperm extraction for some men whose ejaculate no longer contains sperm

Those whose ovarian function has been significantly affected may consider egg donation, which allows them to carry a pregnancy using donor eggs. Men without preserved samples may consider testicular sperm extraction or donor sperm depending on their fertility status after treatment. For survivors with a hereditary cancer syndrome, such as a BRCA variant, preimplantation genetic diagnosis can be discussed as a way to test embryos for that specific variant before transfer.

Timing and Medical Clearance for Cancer Survivors

One of the most important considerations for cancer survivors pursuing fertility treatment is timing and medical clearance. Most oncologists recommend waiting a period of time after finishing treatment before attempting pregnancy, both to allow the body to recover and to monitor for recurrence during the period when it is most likely. Recommended waiting periods vary by cancer type and treatment received, typically ranging from six months to several years. During this time, survivors can work with a fertility team to plan their approach and address preliminary concerns.

Medical clearance from an oncology team is an essential step before starting fertility treatment, because it lets the oncologist weigh whether pregnancy, and the hormones used in fertility treatment, are appropriate given a patient’s cancer type, hormone sensitivity, and overall health. A 2022 review of fertility after cancer published in the journal Cancers found that survivors are diagnosed with infertility more often than women without a cancer history, while also documenting pregnancies achieved through preserved embryos, eggs, and ovarian tissue. Outcomes depend heavily on cancer type, treatment history, and age at diagnosis, which is why our team coordinates closely with oncologists before moving forward.

Considerations for Hormone-Sensitive Breast Cancer

Survivors of hormone receptor-positive breast cancer often take endocrine therapy for years, which can overlap with the window when they hope to conceive. The POSITIVE trial, published in the New England Journal of Medicine in 2023, followed women who paused endocrine therapy to attempt pregnancy and did not find a higher short-term rate of breast cancer events compared with an external control group, though longer follow-up is still under way. Whether a pause is appropriate is a decision for each patient and her oncologist, and fertility protocols that keep estrogen levels lower during stimulation may be discussed when a survivor uses her own eggs.

How Chedid Grieco Supports Cancer Survivors

Cancer survivors often arrive at our practice with more questions than a typical fertility patient, from how prior treatment may have affected their reproductive organs to whether a planned pregnancy carries additional risk. We start every consultation with a review of a patient’s cancer treatment history and, when appropriate, direct communication with their oncology team, so we understand the full picture before recommending a path forward.

From there, we build a plan around what is realistic for that patient, whether that means using previously preserved eggs, sperm, or embryos, exploring egg donation, or considering gestational surrogacy when carrying a pregnancy is not advisable. We also recognize that cancer survivors carry a different kind of emotional weight into fertility treatment, and our team takes time to address those concerns rather than rushing through a standard protocol.

Building Your Family After Cancer Treatment

Dr. Silvana Chedid and the Chedid Grieco team bring decades of experience in reproductive medicine, FDA registration and New York State tissue bank licensing, and an approach built around coordinating with oncology teams. We understand that cancer survivors weigh both medical and emotional considerations that other fertility patients may not face, and we work to give clear, honest guidance at every step rather than promising results we cannot guarantee.

If you are a cancer survivor exploring your fertility options, or you are approaching treatment and want to understand fertility preservation before you begin, our team can walk you through what is realistic for your specific situation. Consultations are held in Miami, with treatment available at our facility in Brazil through our fertility tourism program. Reach out through our contact form to schedule a consultation.

Frequently Asked Questions About Fertility Treatment After Cancer